Sponsor:
Suzanne Lentzsch, MD
Code:
NCT07110844
Conditions
Amyloid Light-chain Amyloidosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Teclistamab
Daratumumab and Hyaluronidase-fihj
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-23. This information was provided to ClinicalTrials.gov by Suzanne Lentzsch, MD on 2025-11-19.